Cargando…

Cinobufacini injection suppresses the proliferation of human osteosarcoma cells by inhibiting PIN1-YAP/TAZ signaling pathway

Cinobufacini injection (CI), an aqueous extract of Cutis Bufonis, is clinically used for cancer therapy in China, but its molecular mechanism for the treatment of osteosarcoma (OS) remains unclear. We constructed U2OS ectopic subcutaneous tumor model to verify the anti-OS effect of CI in vivo. Meanw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuru, Wang, Yanyan, Zhai, Yu, Yuan, Ye, Wang, Junhong, Jin, Yajing, Dang, Lingling, Song, Liming, Chen, Changbao, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063998/ https://www.ncbi.nlm.nih.gov/pubmed/37006999 http://dx.doi.org/10.3389/fphar.2023.1081363

Ejemplares similares

Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway
por: Kong, Lu, et al.
Publicado: (2022)

Comparative Pharmacokinetics of Cinobufacini Capsule and Injection by UPLC-MS/MS
por: Li, Ming, et al.
Publicado: (2022)

Treatment of Huge Hepatocellular Carcinoma Using Cinobufacini Injection in Transarterial Chemoembolization: A Retrospective Study
por: Dong, Jun, et al.
Publicado: (2016)

GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
por: Otkur, Wuxiyar, et al.
Publicado: (2023)

Multifaceted regulation and functions of YAP/TAZ in tumors
por: Liu, Huirong, et al.
Publicado: (2018)

Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells
por: Khanal, Prem, et al.
Publicado: (2019)

Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
por: Lamhamedi-Cherradi, Salah-Eddine, et al.
Publicado: (2021)

YAP/TAZ: Molecular pathway and disease therapy
por: Wei, Yuzi, et al.
Publicado: (2023)

DNA binding partners of YAP/TAZ
por: Kim, Min-Kyu, et al.
Publicado: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

YAP and TAZ regulate cell volume
por: Perez-Gonzalez, Nicolas A., et al.
Publicado: (2019)

Mechanisms of YAP/TAZ transcriptional control
por: Battilana, Giusy, et al.
Publicado: (2021)

YAP/TAZ in Bone and Cartilage Biology
por: Zarka, Mylène, et al.
Publicado: (2022)

YAP/TAZ dull the STING of aging
por: Francisco, Jamie, et al.
Publicado: (2022)

Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023)

Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression
por: Cai, Xiaomin, et al.
Publicado: (2021)

The role of mechano-regulated YAP/TAZ in erectile dysfunction
por: Ji, Mintao, et al.
Publicado: (2023)

Cinobufacini ameliorates experimental colitis via modulating the composition of gut microbiota
por: Bai, Yongfeng, et al.
Publicado: (2019)

Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma
por: Han, Su-xia, et al.
Publicado: (2014)

YAP/TAZ initiate and maintain Schwann cell myelination
por: Grove, Matthew, et al.
Publicado: (2017)

Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
por: Bouvier, Corinne, et al.
Publicado: (2016)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
por: Merritt, Nicole, et al.
Publicado: (2021)

TAZ and YAP are frequently activated oncoproteins in sarcomas
por: Fullenkamp, Colleen A., et al.
Publicado: (2016)

YAP and TAZ are dispensable for physiological and malignant haematopoiesis
por: Donato, Elisa, et al.
Publicado: (2018)

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
por: Azad, Taha, et al.
Publicado: (2019)

YAP and TAZ in Lung Development: The Timing Is Important
por: Warburton, David
Publicado: (2020)

Emerging Principles in the Transcriptional Control by YAP and TAZ
por: Lopez-Hernandez, Alejandro, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression
por: Li, Huapeng, et al.
Publicado: (2019)

Regulation and mechanism of YAP/TAZ in the mechanical microenvironment of stem cells
por: Li, Ying, et al.
Publicado: (2021)

Regulation and mechanism of YAP/TAZ in the mechanical microenvironment of stem cells
por: Li, Ying, et al.
Publicado: (2021)

The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients
por: Yuan, Jia-qi, et al.
Publicado: (2020)

Cinobufacini Injection Improves the Efficacy of Chemotherapy on Advanced Stage Gastric Cancer: A Systemic Review and Meta-Analysis
por: Zhang, Xing, et al.
Publicado: (2018)

Cinobufacini promotes apoptosis of bladder cancer cells by influencing the expression of autophagy-related genes
por: Chen, Dong, et al.
Publicado: (2018)

YAP and TAZ protect against white adipocyte cell death during obesity
por: Wang, Lei, et al.
Publicado: (2020)

The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
por: Luo, Juan, et al.
Publicado: (2023)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

The role of YAP/TAZ activity in cancer metabolic reprogramming
por: Zhang, Xiaodong, et al.
Publicado: (2018)

Relationship between Keloid Formation and YAP/TAZ Signaling
por: Aramaki-Hattori, Noriko, et al.
Publicado: (2017)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_somdmb3srh2quos0g8n740023l